Literature DB >> 11920814

Chronic hepatitis C infection: influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population.

Leila M M B Pereira1, Victorino Spinelli, Ricardo A Ximenes, Maria S Cavalcanti, Raul Melo, Norma Jucá, Masashi Mizokami, Ian G McFarlane.   

Abstract

The distributions of the different genotypes of the hepatitis C virus (HCV) and GBV-C virus (GBV-C/HGV) vary geographically and information worldwide is still incomplete. In particular, there are few data on the distribution of genotypes (and their relationship to the severity of liver disease) in South America. Findings are described in 114 consecutive patients from Northeast Brazil (median age 52 years, range 18-72 years) who had abnormal levels of serum aminotransferases and seropositivity for HCV RNA. The patients were recruited from an outpatient clinic between November 1997 and April 1998. Quantitative HCV RNA and GBV-C/HGV RNA estimations were carried out by double-nested polymerase chain reaction (PCR) using primers from the 5'-untranslated regions (UTRs) of the genomes. HCV genotypes were determined by restriction fragment length polymorphism (RFLP) analysis with 5'-UTR primers and by PCR with type-specific 5'-UTR primers. GBV-C/HGV-RNA genotypes were determined by RFLP with specific 5'-UTR primers and phylogenetic trees were constructed using the Neighbour-Joining and Drawtree programs. Histological features were graded and staged according to international criteria. Of the 114 patients, 35 (30.7%) patients had cirrhosis and 22 (27.8%) had mild, 51 (64.6%) had moderate, and 6 (7.6%) had severe chronic hepatitis. Median HCV viral load was 10(6) genome equivalents per millilitre (range 10(4)-10(9)/ml). Frequencies of genotypes were 5.3% type 1a, 44.7% type 1b, 3.5% type 2, 41.2% type 3, and 5.3% mixed types. GBV-C/HGV-RNA was detected in the sera of 12 (10.5%) patients and was distributed among three phylogenetic groups. There were no significant differences between patients with the predominant HCV genotypes (1b and 3) with respect to gender, age group, viral load, severity of liver disease, or coinfection with GBV-C/HGV. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920814     DOI: 10.1002/jmv.2188

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern India.

Authors:  Vinod K Dixit; Jayanta K Ghosh; Sangey C Lamtha; Pankaj Kaushik; Sundeep K Goyal; Manas K Behera; Neha Singh; Ashok K Jain
Journal:  J Clin Exp Hepatol       Date:  2014-06-18

Review 2.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

3.  GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection.

Authors:  B Boodram; R C Hershow; D Klinzman; J T Stapleton
Journal:  J Viral Hepat       Date:  2011-04       Impact factor: 3.728

4.  Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil.

Authors:  Maria Teresa M Giret; João Luiz Miraglia; Maria Cecília Araripe Sucupira; Anna Nishiya; José Eduardo Levi; Ricardo S Diaz; Ester C Sabino; Esper G Kallas
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

5.  Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study.

Authors:  Luísa Hoffmann; Juliene Antonio Ramos; Elizabeth Valentin de Souza; Ana Lucia de Araújo Ramos; Cristiane Alves Villela-Nogueira; Turán Péter Urményi; Amilcar Tanuri; Edson Rondinelli; Rosane Silva
Journal:  Virol J       Date:  2013-02-14       Impact factor: 4.099

6.  GB Virus C infection in Patients With HIV/Hepatitis C Virus Coinfection: Improvement of the Liver Function in Chronic Hepatitis C.

Authors:  Yue Feng; Li Liu; Yue-Mei Feng; Wenhua Zhao; Zheng Li; A-Mei Zhang; Yuzhu Song; Xueshan Xia
Journal:  Hepat Mon       Date:  2014-03-03       Impact factor: 0.660

7.  Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C.

Authors:  Keyla Santos Guedes de Sá; Ednelza da Silva Graça Amoras; Simone Regina Souza da Silva Conde; Maria Alice Freitas Queiroz; Izaura Maria Vieira Cayres-Vallinoto; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

8.  Hepatitis C virus genotypes and associated risk factors in the state of Pará, Northern Brazil.

Authors:  Geison Luiz Costa de Castro; Ednelza da Graça Silva Amoras; Mauro Sérgio Moura de Araújo; Simone Regina Souza da Silva Conde; Antonio Carlos R Vallinoto
Journal:  Braz J Infect Dis       Date:  2020-07-28       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.